EPLAW PATENT BLOG

NL – Sun v. Novartis

Posted: April 11th, 2017

Sun Pharmaceutical Industries (Europe) B.V. v. Novartis AG, Novartis Pharma GmbH, District Court The Hague, 5 April 2017, Case No. ECLI:NL:RBDHA:2017:3430 The 5 April decision is the final decision in first instance. A previous interim decision was rendered on 25 November 2015 and was published on this blog here. Sun sued Novartis in main proceedings claiming […]

READ MORE

UK – IPCom v. HTC

Posted: March 27th, 2017

IPCom v HTC, UK Court of Appeal, 28 February 2017, neutral citation number [2017] EWCA Civ 90 The Court of Appeal has handed down the latest decision in the long running litigation between IPCom and HTC. IPCom had appealed the High Court’s decision that HTC’s smartphones did not infringe IPCom’s European Patent (UK) 1 841 […]

READ MORE

HU – PI prevents Pharmaceutical Product launch

Posted: March 14th, 2017

Budapest Court Grants Preliminary Injunction Based on Direct Threat of Patent Infringement Preventing Pharmaceutical Product Launch The Metropolitan Court, Budapest has recently issued an order granting preliminary injunction against a Hungarian pharmaceutical distributor. The specialty of the case is that the allegedly infringing pharmaceutical product was not yet launched and it is the first time […]

READ MORE

UK – AP Racing v. Alcon Components

Posted: February 27th, 2017

AP Racing Limited v Alcon Components Limited, Intellectual Property Enterprise Court (HHJ Hacon), 15 February 2017, Neutral Citation Number [2017] EWHC 248 (IPEC) This was the second occasion on which AP Racing and Alcon had come to trial in a dispute over brake callipers for use on racing cars. The first trial, heard in December […]

READ MORE

FR – Warner-Lambert & Pfizer v. generics / Pregabalin PI

Posted: January 20th, 2017

Pregabalin PI in France: a decision dealing with skinny label, second medical use claims and contributory infringement A new pregabalin decision has been rendered on December 2, 2016 in France, in a PI litigation initiated by Warner-Lambert (hereafter: the patentee) and licensees Pfizer against 9 groups of generic companies (hereafter: the defendants). All defendants are […]

READ MORE

NL – DSM v. Novozymes

Posted: January 11th, 2017

DSM IP Assets B.V. v. Novozymes A/S, PI Judge of the District Court of The Hague, The Netherlands, 6 January 2017, Case No. ECLI:NL:RBDHA:2017:110 DSM holps a patent entitled ‘Enzyme preparation yielding a clean taste’. During Opposition, the patent was limited to milk sterilised at ultra high temperatures (‘UHT milk’). An appeal at the TBA […]

READ MORE

NL – RASCO ET AL V. AEBI SCHMIDT

Posted: January 11th, 2017

Rasco D.O.O  and Rondaan Transportservice B.V. v. AEBI Schmidt Nederland B.V., District Court The Hague, The Netherlands, 4 January 2017. Case No. ECLI:NL:RBDHA:2017:4  This matter relates to gritters, more specifically lorries with a detachably mounted device. Aebi Schmidt holds a European patent (the “Patent”). After the District Court had ruled against Aebi Schmidt in preliminary injunction […]

READ MORE

UK – Warner-Lambert v Sandoz II

Posted: January 6th, 2017

Warner-Lambert Company LLC v Sandoz GmbH, UK, High Court (Chancery Division), Mr Justice Arnold, 21 December 2016 These proceedings concerned an application by Sandoz to vary an interim injunction restraining Sandoz from supplying or offering to supply full label generic pregablin granted by Mr Justice Arnold the previous month (“the 17 November Order”). Patent protection […]

READ MORE

NL – HTW v. Permavoid

Posted: January 5th, 2017

HTW Infiltratietechniek B.V. v. Permavoid Limited, Court of Appeal of the Hague, the Netherlands, 27 December 2016, Case number C/09/456139 / HA ZA 13-1362 Permavoid is the holder of European patent EP 1 311 727 B1 for ‘a pavement with structural module’. All claims of EP ‘727 are directed to a ‘vehicular trafficked pavement structure’. […]

READ MORE